Position in BSX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$452,615
-$716,852 QoQ
Shares Held
7,213
-41.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 12.089283238596977.ToString("F0")%
Shared 0.ToString("F0")%
None 87.91071676140302.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Verdence Capital Advisors LLC holds $8,182,815 across 12 Medical Devices names. BSX ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
31,518 | $2,731,034 | |
| 2 | ABT |
Abbott Laboratories
|
15,858 | $1,628,140 | |
| 3 | SYK |
Stryker Corp
|
2,591 | $851,376 | |
| 4 | IRMD |
Iradimed Corp
|
6,611 | $636,374 | |
| 5 | BRKR |
Bruker Corp
|
16,910 | $610,789 | |
| 6 | QDEL |
QuidelOrtho Corp
|
28,412 | $466,809 | |
| 7 | BSX |
Boston Scientific Corp
This page
|
7,213 | $452,615 | |
| 8 | EW |
Edwards Lifesciences Corp
|
3,691 | $295,575 |
All Filings in BSX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $452,615 | 7,213 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,169,467 | 12,265 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,618,510 | 16,578 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $366,375 | 3,411 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $383,545 | 3,802 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $345,579 | 3,869 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $335,786 | 4,007 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $295,872 | 3,842 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $258,001 | 3,767 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $223,493 | 3,866 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||